Adjuvant systemic therapy for breast cancer inBRCA1/BRCA2mutation carriers in a population-based study of risk of contralateral breast cancer
✍ Scribed by Kerryn W. Reding; Jonine L. Bernstein; Bryan M. Langholz; Leslie Bernstein; Robert W. Haile; Colin B. Begg; Charles F. Lynch; Patrick Concannon; Ake Borg; Sharon N. Teraoka; Therese Törngren; Anh Diep; Shanyan Xue; Lisbeth Bertelsen; Xiaolin Liang; Anne S. Reiner; Marinela Capanu; Kathleen E. Malone; The WECARE Collaborative Study Group
- Publisher
- Springer US
- Year
- 2010
- Tongue
- English
- Weight
- 188 KB
- Volume
- 123
- Category
- Article
- ISSN
- 0167-6806
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Early age at first birth and multiparity have been associated with a decrease in the risk of breast cancer in women in the general population. We examined whether this relationship is also present in women at high risk of breast cancer due to the presence of a mutation in either of the